Explore this weekend's OTT releases across Malayalam, Tamil, and Telugu. Thrillers, action, and dramas, including Kishkindha ...

MELD’s market cap is at $2.3 million. Revuto (REVU) is up 27.9% today and shows the potential for a skyrocketing week. Last ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

Syndax Pharmaceuticals (SNDX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kelly ...

A special PMLA court denied bail to Sujit Patkar, linked to Shiv Sena leader Sanjay Raut, for alleged Covid centre irregularities and fraud.

Revuforj is approved for relapsed or refractory acute leukemia with KMT2A translocation in patients aged 1 year and older. The AUGMENT-101 trial showed a 21.2% complete remission rate with a median ...

The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene ...

Syndax Pharmaceuticals won the first FDA approval last week in a new class of medicines called menin inhibitors. The treatment, Rejuforj, will be available as soon as this month for patients with an ...

The streaming platforms are gearing up for a big week with several highly anticipated releases. Here are the must-watch ...

A special CBI court granted bail to four CGST officers in a ₹50 lakh bribery case, marking the release of all accused involved.